Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Concentrated competencies in the fight against infectious diseases

HZI and the Robert Koch Institute sign collaboration agreement. Press date: December 6, 3:15 pm.

Two leaders in the field of infection research are planning on bundling their expertise in the future. Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and at the Robert Koch Institute (RKI) in Berlin and Wernigerode will be sharing their resources and potentials to find answers to pressing questions of infection research and epidemiology. The two research institutes' directors will sign the agreement on December 6.

Bacterial antibiotic resistance, vaccine development, and new insights into the epidemiology and ecology of pathogenic bacteria - these are topics that the HZI and the RKI will approach together in the future. As a member of the Helmholtz Association, the HZI's long-term research goal is to maintain and improve the human condition. The centre contributes decisively to this goal by providing the basis for new diagnostic tools, drugs, and therapies.

The focus is on conducting basic research. At the RKI, one of the world's oldest biomedical research institutes, applied and measure oriented work is carried out. It is the national Public-health institute in Germany. The most important work areas are the control of infectious diseases and the analysis of long-term health trends within the population. With regard to the recognition of new health risks, the RKI has an “antenna function” in terms of a rapid alert system.

HZI and RKI scientists are already working together on common questions. For instance, Prof. Petra Dersch, head of one of HZI's research departments, is studying pathogenic bacterial strains that were isolated from patients and previously characterized at the RKI. Both facilities are planning on working together more closely in the future. Prof. Dirk Heinz, HZI's scientific director, is convinced that "the agreement will continue to strengthen our collaborative partnership as well as facilitate joint research projects." “The institutes' scientific exchange promises several synergistic effects that will benefit the general public in the long run,” explains RKI's president Prof. Reinhard Burger.

One of the goals is new antibiotic development, which is desperately needed in light of increasing resistance of many pathogenic bacteria. Experts are certain that the new collaboration would be promising in terms of methodologies as well. As such, the scientists are interested in developing new vaccines and diagnostic tools for the detection of infectious diseases.

The institutes also aim at conducting joint epidemiological research. What is the etiology of a particular disease? How do diseases spread? What course do they take? Quantifying the answers to these questions and making predictions is the job of epidemiology. For some time now, Prof. Gérard Krause has been the embodiment of both institutes' functional aspects: Not only does he head RKI's Department of Infectious Disease Epidemiology, representing Germany in several international networks in this capacity - since last year, he also heads HZI's Department of Epidemiology. Krause sees one of the collaboration's advantages in "the two departments' distinct methodological approaches, which complement each other perfectly."

On December 6, Prof. Heinz and Prof. Burger will be signing the collaboration agreement at a symposium. Following the signing, media representatives are invited to a press date at 3:15 pm. For additional information, please call (+49) 531-61811401.

The Helmholtz Centre for Infection Research:
At the Helmholtz Centre for Infection Research (HZI) in Braunschweig, scientists are studying microbial virulence factors, host-pathogen interactions and immunity. The goal is to develop strategies for the diagnosis, prevention and therapy of human infectious diseases.

Dr. Birgit Manno | Helmholtz-Zentrum
Further information:

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>